Чтение онлайн

108.Tsuchiya R., Asamura H., Kondo H. et al. Extended recection of the left atrium, great vessels, or both for lung cancer. Ann Torac Surg, 1994, 57 (4): 960-5.

109.Hirai T., Yoshida I., Kawashima O., Kamiyoshihara M. et al. T4 lung cancer: surgical indications based on results of surgical treatment Kyobu Geka. 1997 Feb;50(2):106-9

110.Bobbio A., Carbognani P., Grapeggia M. et al. Surgical outcome of combined pulmonary and atrial resection for lung cancer. Thorac cardiovasc Surg., 2004,Jun;52(3):180-2.

111.Ratto GB, Costa R, Vassallo G. et al.Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer. Ann Thorac Surg. 2004 Jul;78(1):234-7.

112.Брюсов П.Г., Васюкевич А.Г., Фокин А.В. Комбинированные операции в тактике лечения немелкоклеточного рака легкого III стадии. IX Российский онкологический конгресс, 22-24 ноября,Москва 2005, с.167.

113.Doddoli C, Rollet G, Thomas P. et al. Is lung cancer surgery justified in patients with direct mediastinal invasion? Eur J Cardiothorac Surg. 2001 Aug;20(2):339-43.

114.Guggino G, Doddoli C, Barlesi F. et al. Completion pneumonectomy in cancer patients: experience with 55 cases. Eur J Cardiothorac Surg. 2004 Mar;25(3):449-55.

115.Thomas P., Magnan P.E., Moulin G. et al. Extended operation for lung cancer invading the superior vena cava.Eur J Cardiothorac Surg. 1994;8(4):177-82.

116.Watanabe S., Oda M, Tomita Y. et al. Extended resection of the great vessels for primary lung cancer and mediastinal tumor. Kyobu Geka. 1999 Jan;52(1):4-7

117.Xu GC, Rong TH , Lin P. Adjuvant chemotherapy following radical surgery for non-small-cell lung cancer: a randomized study on 70 patients. Chin Med J 2000;113(7):617-620

118.Spaggiari L, Veronesi G, D'Aiuto M, Tosoni A. Superior vena cava reconstruction using heterologous pericardial tube after extended resection for lung cancer. Eur J Cardiothorac Surg. 2004 Sep;26(3):649-51.

119.Suzuki K., Asamura H., Watanabe S., Tsuchiya R. et al. Combined resection of superior vena cava for lung carcinoma: prognostic significance of patterns of superior vena cava invasion. Ann Thorac Surg. 2004 Oct;78(4):1184-9; discussion 1184-9

120.Downey R. J., Rusch V., Hsu F. I. et al. Chest wall resection for locally recurrent breast cancer: Is it worthwhile? J. Thorac. Cardiovasc. Surg. 2000, 119:420-8.

121.Volpino P., Cangemi B, Frati R. et al. Surgical approach to non-small cell lung cancer involving the chest wall. J Exp Clin Cancer Res. 2000 Mar;19(1):41-4.

122.Burkhart H M., Allen M S., Nichols F C. et al. Results of en bloc resection for bronchogenic carcinoma with chest wall invasion. J Thorac Cardiovasc Surg 2002;123:670-5

123.Roviaro G., Varoli F.; Grignani F. Non-small Cell Lung Cancer With Chest Wall Invasion Chest. 2003;123:1341-1347.

124.Matsuoka H, Nichio W., Okada M. et al. Resection of chest wall invasion in patients with non-small cell lung cancer.Eur J Cardiothorac Surg. 2004 Dec;26(6):1200-4.

125.Facciolo F., Cardillo G., Lopergolo M., et al. Chest wall invasion in non-small cell lung carcinoma: a rationale for en bloc resection. J. Thorac. Cardiovasc. Surg., 2001, 121:649-56.

126.Yokoi K, Tsuchiya R, Mori T, et al. Results of surgical treatment of lung cancer involving diaphragm. J Thorac Cardiovasc Surg 2000; 120: 799 - 805.

127.Pearson FG, DeLarue NC, Ilves R, et al: Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 83:1, 1982

128.Tanaka F, Yanagihara K, Otake Y, Prognostic factors in resected pathologic (p-) stage IIIA-N2, non-small-cell lung cancer. Ann Surg Oncol. 2004 Jun;11(6):612-8.

129.Ohta Y., Shimixu Y., Minato H. et al. Results of initial operations in non-small cell lung cancer patients with single-level N2 disease. Ann Thorac Surg. 2006 Feb;81(2):427-33.

130.Suzuki K., Nagai K., Yoshida J. et al. The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status.J Thorac Cardiovasc Surg. 1999 Jul;118(1):145-53.

131.Усков Д.А., Макеева И.В., Поме А.В. и др. Неоадьювантная химиотерапия немелкоклеточного рака легкого. Росс. Онкол. Журнал, 2001, N 3, с. 4-9.

132.Добродеев А.Ю. Комбинированное лечение рака легкого с интраоперационной лучевой терапией в условиях радиосенсибилизации цисплатином. Автореф. Дисс. На соиск., учен., степ., канд., мед., наук, Томск, 2004, 20 с.

133.Потанин А.В. Отдаленные результаты хирургического и комбинированного лечения больных немелкоклетьочным раком легкого . Автореф. Дисс. На соиск., учен., степ., канд., мед., наук, Казань, 2005, 24 с.

134.Maas K.W., van Swieten H.A., van Munnink V., Hofman P. et al. Combined modality treatment in stage IIIA/B non-small cell lung cancer. Citation: Lung Cancer 2003, Vol. 41, Supplement 2, Page 155.

135.De Leyn P., Decker G. Surgical treatment of non-small cell lung cancer. Rev Mal Respir, November 1, 2004; 21(5 Pt 1): 971-82.

136.Bradley J.D., Paulus R., Graham M.V., Ettinger D.S. et al. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group - RTOG 9705. J.Clin Oncol., 2005, may 20;23(15):3480-7.

137.Machtay B M., Lee J. H., Shrager J.B., Kaiser L.R. et al. Risk of Death From Intercurrent Disease Is Not Excessively Increased by Modern Postoperative Radiotherapy for High-Risk Resected Non - Small-Cell Lung Carcinoma. Journal of Clinical Oncology, Vol 19, Issue 19 (October), 2001: 3912-3917

138.Stamatis G., Wilke H., Eberhardt W., Budach V. et al. Surgery of locally advanced non-small cell bronchial cancer after intensive preoperative chemo-/radiotherapy. Chirurg. 1994, Jan; 65(1):42-7.

139.Takamori S., Rikimaru T., Hayashi A., Tayama K, et al. A preoperative alternating chemotherapy and radiotherapy program for patients with stage IIIA (N2) non-small cell lung cancer. Cancer. 2000 Jul;29(1):49-56.

140.Hainsworth J.D., Gray J.R., Litchy S., Bearden J.D. et al. A phase II trial of preoperative concurrent radiation therapy and weekly paclitaxel/carboplatin for patients with locally advanced non-small-cell lung cancer. Clin Lung Cancer. 2004 Jul;6(1):33-42.

141.Friedel G., Hruska D., Budach W., Wolf M. et al. Neoadjuvant chemoradiotherapy of stage III non-small-cell lung cancer. Lung Cancer. 2000 Dec;30(3):175-85.